A
Assertio
A leading commercial pharmaceutical company bringing differentiated products to patients
About Assertio
Assertio Holdings, Inc. is a prominent commercial pharmaceutical company specializing in the development and distribution of branded prescription products. The company focuses on three primary therapeutic areas: neurology, hospital care, and pain and inflammation. Assertio serves a diverse range of clients, including healthcare providers, hospitals, and patients who require specialized medications for chronic and acute conditions. Operating within the pharmaceutical market, Assertio leverages business development strategies such as licensing, mergers, and acquisitions to expand its product portfolio and market reach. The business model is centered around the commercialization of differentiated pharmaceutical products, ensuring compliance with legal and regulatory standards while maintaining high ethical standards. Revenue is generated through the sale of prescription medications, supported by strategic partnerships and a commitment to innovation in therapeutic solutions.
Source: Dealroom company dataAt a glance
- Status
- Listed
- Founded
- 1995
- Headquarters
- Newark, United States
- Listing
- IPO 1997
- Sector
- Biotech & Life Sciences
- Power Law
- Thoroughbred$100M+ revenue
Knowledge graph
More headlines
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series B and later5 investors entered at this stage
Thomas Weisel Partners
RBC Capital Markets
Morgan Stanley- PHPharmakon Holdings
Deerfield
Source: Dealroom Talent Intelligence.
Global footprint
team presence
across markets
Patents
27 active patent families included in this estimate.
A patent family groups patent filings for the same invention. Source: Dealroom · PatSnap.
Market sentiment
An AI-synthesised read of the highest-engagement posts about Assertio on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Assertio on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.